0001974158-24-000068.txt : 20240819
0001974158-24-000068.hdr.sgml : 20240819
20240819163208
ACCESSION NUMBER: 0001974158-24-000068
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240819
DATE AS OF CHANGE: 20240819
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 241221066
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kintz Samuel
CENTRAL INDEX KEY: 0001967168
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: ENLIVEN THERAPEUTICS INC
STREET 2: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
144
1
primary_doc.xml
144
0001967168
XXXXXXXX
LIVE
0001672619
Enliven Therapeutics, Inc.
001-39247
6200 LOOKOUT ROAD
BOULDER
CO
80301
720-647-8519
Kintz Samuel
Member of immediate family of any of the foregoing
Common
Jefferies LLC
520 Madison Ave
4th Fl
New York
NY
10022
30000
711300.00
47000000
08/19/2024
NASDAQ
Common
09/01/2019
Founder Shares
Enliven Therapeutics
N
30000
09/01/2019
N/A
N
Samuel Kintz
6200 Lookout Road
1st Fl
Boulder
CO
80301
Enliven Therapeutics
05/28/2024
12000
278210.40
Samuel Kintz
6200 Lookout Road
1st Fl
Boulder
CO
80301
Enliven Therapeutics
06/25/2024
12000
259901.16
Samuel Kintz
6200 Lookout Road
1st Fl
Boulder
CO
80301
Enliven Therapeutics
07/25/2024
12000
299072.28
Samuel Kintz
6200 Lookout Road
1st Fl
Boulder
CO
80301
Enliven Therapeutics
07/31/2024
2270
62555.00
All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 04/18/2024, and all representations regarding material non-public information were made as of the adoption of the plan. The shares in this filing will be sold from Elliot Egan Kintz Irrevocable Trust UAD 10/26/2021.
08/19/2024
04/18/2024
Samuel Kintz